These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1493724)

  • 1. Mechanisms of progression of diabetic nephropathy. Conclusions based on clinical observations.
    Aurell M; Björck S
    Contrib Nephrol; 1992; 98():125-32. PubMed ID: 1493724
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of diabetic nephropathy: a rational approach based on its pathophysiology.
    Tuttle KR; DeFronzo RA; Stein JH
    Semin Nephrol; 1991 Mar; 11(2):220-35. PubMed ID: 1674623
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathophysiology of diabetic nephropathy: involvement of multifaceted signalling mechanism.
    Balakumar P; Arora MK; Reddy J; Anand-Srivastava MB
    J Cardiovasc Pharmacol; 2009 Aug; 54(2):129-38. PubMed ID: 19528810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Can progression to terminal renal insufficiency be avoided in diabetic nephropathy?].
    Luño J; Valderrábano F
    An Med Interna; 1998 Nov; 15(11):567-71. PubMed ID: 9882851
    [No Abstract]   [Full Text] [Related]  

  • 5. [The kidney as a target organ in diabetic patients with arterial hypertension].
    Viberti G
    Drugs; 2003; 63 Spec No 1():31-7. PubMed ID: 12708880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of progressive renal disease in diabetes mellitus.
    Aurell M; Björck S
    Kidney Int Suppl; 1992 May; 36():S38-42. PubMed ID: 1614066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Early detection and control of risk factors in diabetic nephropathy].
    Fernández López MT; Isidro San Juan ML; Cordido F
    An Med Interna; 1998 Nov; 15(11):600-5. PubMed ID: 9882860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of endocrine changes and of hypertension in the progression of diabetic renal failure in patients following a low protein diet supplemented with essential amino acids and keto-analogues.
    Ciardella F; Barsotti G; Niosi F; Morelli E; Petronio MG; Mazzotta L; Mantovanelli A; Caprioli R; Mosaico A; Giovannetti S
    Scand J Urol Nephrol Suppl; 1988; 108():41-6. PubMed ID: 3163830
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk factors of renal failure progression two years prior to dialysis.
    Mazouz H; Kacso I; Ghazali A; El Esper N; Moriniere P; Makdassi R; Hardy P; Westeel PF; Achard JM; Pruna A; Fournier A
    Clin Nephrol; 1999 Jun; 51(6):355-66. PubMed ID: 10404696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies to slow the progression of renal disease.
    Neuringer JR; Levey AS
    Semin Nephrol; 1994 May; 14(3):261-73. PubMed ID: 8036361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant macro and microvascular complications in diabetic nephropathy.
    Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nephrosclerosis. The Cinderella of chronic kidney disease].
    Martín R; Gorostidi M; Díez Ojea B
    Nefrologia; 2010; 30(3):275-9. PubMed ID: 20514095
    [No Abstract]   [Full Text] [Related]  

  • 14. [Control of arterial pressure in diabetic nephropathy].
    Luño J; García de Vinuesa S
    Nefrologia; 2001; 21(3):240-5. PubMed ID: 11471304
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypertension in diabetes mellitus.
    Hasslacher C; Ritz E; Tschöpe W; Gallasch G; Mann JF
    Kidney Int Suppl; 1988 Sep; 25():S133-7. PubMed ID: 3184604
    [No Abstract]   [Full Text] [Related]  

  • 16. Diabetic nephropathy: a nephrological point of view.
    Chanard J
    Diabetes Metab; 2000 Jul; 26 Suppl 4():4-5. PubMed ID: 10922966
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current questions concerning the pathomechanism of diabetic nephropathy].
    Mogyorósi A; de Châtel R; Ziyadeh FN
    Orv Hetil; 1996 Dec; 137(51):2845-50. PubMed ID: 9679619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic nephropathy. Aspects of pathophysiology and treatment.
    Hansen HP
    Dan Med Bull; 2003 Nov; 50(4):401-22. PubMed ID: 14694854
    [No Abstract]   [Full Text] [Related]  

  • 19. Protective effect of an oral adsorbent on renal function in chronic renal failure: determinants of its efficacy in diabetic nephropathy.
    Sanaka T; Akizawa T; Koide K; Koshikawa S
    Ther Apher Dial; 2004 Jun; 8(3):232-40. PubMed ID: 15154877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic nephropathy. A clinical study of risk factors in type-I diabetes mellitus.
    Nordén G
    Scand J Urol Nephrol Suppl; 1988; 116():1-76. PubMed ID: 3227321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.